Join
Live feed
·
INSIDERFilingvia Quantisnow
Denali Therapeutics Inc. logo

Director Schenkein David P exercised 47,165 shares at a strike of $18.00 and sold $1,932,665 worth of shares (59,441 units at $32.51), decreasing direct ownership by 57% to 9,220 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNLI (Denali Therapeutics Inc.) and more on Quantisnow.